Company Performance - Cigna reported quarterly earnings of 6.64pershare,missingtheZacksConsensusEstimateof7.83 per share, and down from 6.79pershareayearago,representinganearningssurpriseof−15.2065.68 billion for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 3.85%, and up from 51.15billionyear−over−year[2]−Overthelastfourquarters,CignahassurpassedconsensusEPSestimatesthreetimesandtoppedconsensusrevenueestimatesfourtimes[2]StockOutlook−Cignashareshaveincreasedapproximately9.86.89 on revenues of 59.68billion,andforthecurrentfiscalyear,itis31.57 on revenues of $249.9 billion [7] - The estimate revisions trend for Cigna is currently favorable, leading to a Zacks Rank 2 (Buy) for the stock, indicating expected outperformance in the near future [6] Industry Context - The Medical - HMOs industry, to which Cigna belongs, is currently in the bottom 36% of over 250 Zacks industries, which may impact stock performance [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, suggesting that investors should monitor these revisions closely [5]